Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction

NCT06379152 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT06379152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06379152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Unknown status
Start date
September 20, 2020
Completion date
July 1, 2024
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, prognathism